investordatabase.org

Aglaia Management B.V.

aglaia-oncology.com Direct investor

Aglaia Management B.V. is a venture capital firm that invests in oncology drug development companies. It manages alternative investment funds and has invested in 12 early stage companies, 6 of which it founded.

Aglaia Management B.V. is a venture capital firm headquartered in Bilthoven, Netherlands. It invests directly in companies, at seed, in oncology, drug development and life sciences. 12 portfolio companies, as it reports.

“Aglaia invests in oncology drug development companies.”

— Aglaia Management B.V., own website
Layer
Direct investor
Type
Venture capital
Stage
Seed
Headquarters
Bilthoven, Netherlands
Sectors
oncology, drug development, life sciences
Portfolio
12 companies
How to reach it
Its contact page on its own site

Team, as Aglaia Management B.V. publishes it

  • Karl Rothweiler Partner
  • Folkert van Cleef Partner
  • Eric van der Putten Partner
  • Mark Krul Partner
  • Ernst Geutjes Venture Partner

Names and roles exactly as listed on aglaia-oncology.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 9 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

Where this comes from

Every fact above was read from a page Aglaia Management B.V. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 9280 · added 2026-09-29 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under